153 results
Page 4 of 8
8-K
EX-10.1
497ns1zyzjwpj
7 Apr 22
Entry into a Material Definitive Agreement
4:47pm
424B3
7t06 7p3f
7 Apr 22
Prospectus supplement
4:46pm
8-K
EX-10.1
ptmk2b7si
22 Mar 22
Entry into a Material Definitive Agreement
6:05am
S-3
EX-5.1
bpc j1mctu6wecsw
4 Feb 22
Shelf registration
4:36pm
S-3
jbz4k62vhgw
4 Feb 22
Shelf registration
4:36pm
8-K/A
EX-99.3
4oymxd0hh3luwfu
22 Dec 21
Audited Financial Statements
12:00am
8-K/A
EX-99.1
1i5ym3gjge t0
22 Dec 21
Audited Financial Statements
12:00am
DEF 14A
vog7j8
28 Oct 21
Definitive proxy
3:07pm
8-K
EX-2.1
vw2 orfww
13 Oct 21
InMed Pharmaceuticals Completes Acquisition of BayMedica Creating a Market Leader in the Manufacturing of Rare Cannabinoids
5:00pm
10-K
EX-4.6
qdrm0
24 Sep 21
Annual report
7:31am
10-K
EX-2.1
tf33 w0p1
24 Sep 21
Annual report
7:31am
10-K
7qybi5wmz 3wf3rxd27
24 Sep 21
Annual report
7:31am
10-K
EX-10.10
l6sp6iw
24 Sep 21
Annual report
7:31am
10-K
EX-4.7
yv5 g2xektae39ky0sz
24 Sep 21
Annual report
7:31am
424B3
22bfqtbhld sc
22 Jul 21
Prospectus supplement
10:27am